Beta
Back to CB.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

CB Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, R&D Expenses remained at $0, while SG&A Expenses reported no data, resulting in total operating expenses of $0 for the period. This marks a complete absence of reported figures for both categories in the latest quarter. From Q2'23 to Q4'25, operating expenses were driven entirely by SG&A, which showed a steady upward trend from $969M in Q2'23 to a peak of $1.16B in Q4'25, reflecting consistent growth with minor fluctuations, such as a slight dip to $1.08B in Q1'25. R&D Expenses consistently held at $0 across the entire timeframe from Q2'23 to Q1'26, indicating no allocation or reporting in this category, with the stacked bar chart highlighting SG&A as the sole contributor to the overall increasing expense profile.